Key findings from one of the largest real-world databases of ketamine treatment outcomes:
-65% of patients responded after 4 infusions
-PCL-5 scores dropped from 47 to 27 on average
-90% of patients had comorbid Major Depressive Disorder
With only 20-30% of PTSD patients achieving remission with traditional treatments, these results offer hope for those with complex, treatment-resistant cases—especially after the FDA blocked MDMA-AT back in August.
Comments
-65% of patients responded after 4 infusions
-PCL-5 scores dropped from 47 to 27 on average
-90% of patients had comorbid Major Depressive Disorder
https://www.osmind.org/blog/ketamine-therapy-ptsd